147 related articles for article (PubMed ID: 29157619)
21. Transformation of HHV-8-negative idiopathic multicentric Castleman disease into diffuse large B-cell lymphoma: A case report from Nepal.
Gupta A; Anand A; Hussain SH; Shah R; Ranjan R; Subedi V; Baral A; Mishra A; Pradhan A; Dulal S
Clin Case Rep; 2023 Sep; 11(9):e7903. PubMed ID: 37705586
[TBL] [Abstract][Full Text] [Related]
22. A rare presentation of Castleman disease.
Surjit A; Vk S; Ps S; Najeeb SA
Clin Med (Lond); 2023 Nov; 23(Suppl 6):6. PubMed ID: 38182256
[No Abstract] [Full Text] [Related]
23. Adenopathy and Extensive Skin patch Overlaying a Plasmacytoma and other proliferation (AESOP) syndrome associated with Hodgkin lymphoma.
Saucereau J; Legeas C; Schoenlaub P
Ann Dermatol Venereol; 2024 Mar; 151(1):103256. PubMed ID: 38442467
[No Abstract] [Full Text] [Related]
24. Signature of Castleman disease in gastrointestinal mucosal biopsies and resected specimen: report of four cases and literature review.
Patra S; Acharya P; Padhi S; Chandra Samal S; Mishra P; Panigrahi MK; Panigrahi C
Pathology; 2023 Aug; 55(5):703-707. PubMed ID: 36907779
[No Abstract] [Full Text] [Related]
25. Clinical and dermoscopic features of Castelman's disease: insights from an emblematic case.
Paolino G; Della Torre E; Moroni L; Rizzo N; Bongiovanni L; DI Nicola MR; Ramirez GA; Brianti P; Dagna L; Mercuri SR
Ital J Dermatol Venerol; 2022 Oct; 157(5):462-463. PubMed ID: 36213978
[No Abstract] [Full Text] [Related]
26. Retraction: Unicentric Castleman Disease With Systemic Symptoms: A Rare Case From Family Practice.
Aljuaid AK; Iskandar MN; Almalki AA; Alsuqayh KS; Almufarrih YA; Alosaimi SG; Aljamaan LF; Aldaihani SF; Alghamdi SA; Alaamree MA; Fageeh LM; Almagrafi SA; Al Halbub AY; Alghamdi ZS; Al-Hawaj F
Cureus; 2024 Jan; 16(1):r123. PubMed ID: 38274625
[TBL] [Abstract][Full Text] [Related]
27. Treatment of Idiopathic Castleman Disease.
van Rhee F; Greenway A; Stone K
Hematol Oncol Clin North Am; 2018 Feb; 32(1):89-106. PubMed ID: 29157622
[TBL] [Abstract][Full Text] [Related]
28. Castleman Disease.
van Rhee F; Munshi NC
Hematol Oncol Clin North Am; 2018 Feb; 32(1):xiii-xiv. PubMed ID: 29157623
[No Abstract] [Full Text] [Related]
29. Castleman Disease and Rosai-Dorfman Disease.
Piris MA; Aguirregoicoa E; Montes-Moreno S; Celeiro-Muñoz C
Semin Diagn Pathol; 2018 Jan; 35(1):44-53. PubMed ID: 29217303
[TBL] [Abstract][Full Text] [Related]
30. Castleman Disease.
Wang W; Medeiros LJ
Surg Pathol Clin; 2019 Sep; 12(3):849-863. PubMed ID: 31352991
[TBL] [Abstract][Full Text] [Related]
31. Lymphadenopathy associated with IgG4-related disease: Diagnosis & differential diagnosis.
Wick MR; O'Malley DP
Semin Diagn Pathol; 2018 Jan; 35(1):61-66. PubMed ID: 29157939
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease.
Lurain K; Yarchoan R; Uldrick TS
Hematol Oncol Clin North Am; 2018 Feb; 32(1):75-88. PubMed ID: 29157621
[TBL] [Abstract][Full Text] [Related]
33. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.
van Rhee F; Voorhees P; Dispenzieri A; Fosså A; Srkalovic G; Ide M; Munshi N; Schey S; Streetly M; Pierson SK; Partridge HL; Mukherjee S; Shilling D; Stone K; Greenway A; Ruth J; Lechowicz MJ; Chandrakasan S; Jayanthan R; Jaffe ES; Leitch H; Pemmaraju N; Chadburn A; Lim MS; Elenitoba-Johnson KS; Krymskaya V; Goodman A; Hoffmann C; Zinzani PL; Ferrero S; Terriou L; Sato Y; Simpson D; Wong R; Rossi JF; Nasta S; Yoshizaki K; Kurzrock R; Uldrick TS; Casper C; Oksenhendler E; Fajgenbaum DC
Blood; 2018 Nov; 132(20):2115-2124. PubMed ID: 30181172
[TBL] [Abstract][Full Text] [Related]
34. Unicentric Castleman Disease.
Wong RSM
Hematol Oncol Clin North Am; 2018 Feb; 32(1):65-73. PubMed ID: 29157620
[TBL] [Abstract][Full Text] [Related]
35. Overview of Castleman disease.
Dispenzieri A; Fajgenbaum DC
Blood; 2020 Apr; 135(16):1353-1364. PubMed ID: 32106302
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and Management of Castleman Disease.
Abramson JS
J Natl Compr Canc Netw; 2019 Nov; 17(11.5):1417-1419. PubMed ID: 31766018
[TBL] [Abstract][Full Text] [Related]
37. POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management.
Dispenzieri A
Am J Hematol; 2019 Jul; 94(7):812-827. PubMed ID: 31012139
[TBL] [Abstract][Full Text] [Related]
38. Primary effusion lymphoma in Taiwan shows two distinctive clinicopathological subtypes with rare human immunodeficiency virus association.
Chen BJ; Wang RC; Ho CH; Yuan CT; Huang WT; Yang SF; Hsieh PP; Yung YC; Lin SY; Hsu CF; Su YZ; Kuo CC; Chuang SS
Histopathology; 2018 May; 72(6):930-944. PubMed ID: 29206290
[TBL] [Abstract][Full Text] [Related]
39. Classic Hodgkin lymphoma and Castleman disease: an entity appears to be emerging.
Lyapichev KA; You MJ; Vega F; Solis LM; Medeiros LJ
Virchows Arch; 2020 Sep; 477(3):437-444. PubMed ID: 32152665
[TBL] [Abstract][Full Text] [Related]
40. Clinical, laboratory and imaging findings in Castleman's disease - The subtype decides.
Haap M; Wiefels J; Horger M; Hoyer A; Müssig K
Blood Rev; 2018 May; 32(3):225-234. PubMed ID: 29223447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
